FMP
Regencell Bioscience Holdings Limited
RGC
NASDAQ
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
18.5 USD
5.88 (31.78%)
RGC Financial Statements
Year
2024
2023
2022
2021
Current Assets
8.11M
11.62M
16.44M
66.85k
Cash & Short Term Investments
7.96M
11.56M
16.42M
59.41k
Cash And Cash Equivalents
2.96M
1.56M
6.42M
59.41k
Short Term Investments
5M
10M
10M
0
Net Receivables
152.78k
0
0
0
Inventory
0
-56.55k
-27.6k
-7.44k
Other Current Assets
0
56.55k
0
0
Non-Current Assets
324.2k
1M
1.57M
273.29k
Property, Plant & Equipment
226.51k
891.91k
1.46M
81.86k
Goodwill And Intangible Assets
0
0
0
0
Goodwill
0
0
0
0
Intangible Assets
0
0
0
0
Long Term Investments
0
0
0
0
Tax Assets
0
0
0
0
Other Non-Current Assets
97.68k
108.5k
114.3k
191.42k
Other Assets
0
0
-0
0
Total Assets
8.44M
12.62M
18.02M
340.13k
-
-
-
-
Current Liabilities
193.58k
606.91k
577.76k
4.34M
Accounts Payable
0
0
0
0
Short Term Debt
0
0
0
3.68M
Tax Payables
0
0
0
0
Deferred Revenue
0
0
0
0
Other Current Liabilities
0
0
0
0
Total Current Liabilities
193.58k
606.91k
577.76k
4.34M
Total Non-Current Liabilities
25.93k
25.41k
360.27k
0
Long-Term Debt
0
0
0
0
Deferred Revenue
0
0
0
0
Deferred Taxes Liabilities
0
0
0
0
Other Non Current liabilities
0
0
0
0
Total Liabilities
219.51k
632.32k
938.03k
4.34M
Other Liabilities
0
0
0
0
Stockholders Equity
8.22M
12.03M
17.07M
-4M
Common Stock
130
130
130
100
Retained Earnings
-21.62M
-17.32M
-11.44M
-4M
Accumulated Other Comprehensive Income/Loss
-45.77k
-86.66k
0
0
Other Shareholders Equity
0
0
0
0
Total Liabilities and Stockholders Equity
8.44M
12.62M
18.02M
340.13k
All figures are in USD.
